#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3616294	B	Displacement of [3H]N6-R-phenylisopropyladenosine from human adenosine A1 receptor expressed in CHO cell membranes at 10 uM	Homo sapiens	15	ALA3612017	cell-based format	Scientific Literature
2.	ALA3616296	B	Displacement of [3H]2-[p-(2-carboxyethyl)phenyl-ethylamino]-5'-Nethylcarboxamidoadenosine from human adenosine A2A receptor expressed in HEK293 cell membranes at 10 uM	Homo sapiens	18	ALA3612017	cell-based format	Scientific Literature
3.	ALA3616297	B	Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide from human adenosine A3 receptor expressed in CHO cell membranes	Homo sapiens	18	ALA3612017	cell-based format	Scientific Literature
4.	ALA3616300	B	Binding affinity to mouse adenosine A3 receptor expressed in HEK293 cell membranes	Mus musculus	5	ALA3612017	cell-based format	Scientific Literature
5.	ALA3616301	B	Binding affinity to canine adenosine A3 receptor expressed in HEK293 cell membranes	Canis lupus familiaris	5	ALA3612017	cell-based format	Scientific Literature
6.	ALA3616304	F	Analgesic activity in mouse chronic constriction injury model of neuropathic pain assessed as protection of ipsilateral hind paw mechanoallodynia of sciatic nerve at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7 relative to control measured at 1 hr	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
7.	ALA3616305	F	Analgesic activity in mouse chronic constriction injury model of neuropathic pain assessed as protection of ipsilateral hind paw mechanoallodynia of sciatic nerve at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7 measured at 3 hrs	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
8.	ALA3616306	F	Analgesic activity in mouse chronic constriction injury model of neuropathic pain assessed as time of peak protection at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
9.	ALA3616307	F	Analgesic activity in mouse chronic constriction injury model of neuropathic pain assessed as protection of ipsilateral hind paw mechanoallodynia of sciatic nerve at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7	Mus musculus	2	ALA3612017	organism-based format	Scientific Literature
10.	ALA3616311	A	Effect on contralateral side hind paw in mouse chronic constriction injury model of neuropathic pain at 0.3 to 30 umol/kg administered through oral gavage at point of peak pain on day 7	Mus musculus	11	ALA3612017	organism-based format	Scientific Literature
11.	ALA4731036	A	Stability in Sprague-Dawley rat plasma	Rattus norvegicus	5	ALA4725439	cell-free format	Scientific Literature
12.	ALA4731037	A	Stability in Sprague-Dawley rat liver microsomes	Rattus norvegicus	5	ALA4725439	microsome format	Scientific Literature
13.	ALA4731038	A	Cytotoxicity against human HepG2 cells	Homo sapiens	5	ALA4725439	cell-based format	Scientific Literature
14.	ALA4731039	A	Oral bioavailability in Sprague-Dawley rat	Rattus norvegicus	5	ALA4725439	organism-based format	Scientific Literature